Nifty Midcap 100 index snapped its four-session losing streak to gain up to 1%.
Both the models are offered at starting prices of Rs 5,99,900 for Prime HB and Rs 6,89,900 for Prime SD (ex-showroom).
Ajanta Pharma shares touched a high of Rs 2,784.80, up 3.52 percent. The scrip has risen for the last two trading sessions.
Nifty Defence index has now declined over 2 percent in the last three sessions. In Tuesday’s trade, 16 of the 18 constituents of the index were trading in the red.
Tata group-backed jewellery maker has announced its entry into the lab-grown diamond space under the brand name 'beYon'.
The MIP, if approved, may potentially enable domestic capacity to survive the price onslaught of Chinese suppliers and will also make Aurobindo Pharma's investment under India’s Production-Linked Incentive (PLI) scheme viable.
Buying interest emerged after the company said it had received an order worth Rs 725 crore from NTPC Renewable Energy for the development of a 250 MW solar project.
Monday’s rally was the sharpest single-day rise in the Hindustan Copper stock since April 2010, following a surge in copper prices to record levels on the London Metal Exchange.
As we transition into 2026, market direction will be shaped by three key factors: currency volatility, foreign institutional investor flows, and developments in India-US trade discussions
The brokerage has set a price target of Rs 2,000 per share for Midwest, implying an upside of about 23 percent.
RVNL led the rally, climbing as much as 12.58 percent to Rs 389.20 on the NSE
Hindustan Zinc stock opened with a gap-up of 3.22% and climbed to an intraday high of Rs 646.50 on the NSE, which also marked its 52-week high.
Silver touched an all-time high of $72.70 an ounce and was last trading 0.9 percent higher at $72.09 in international market.
ICICI Securities expects margin expansion and stronger cash flow generation on the back of operational efficiencies.
Hindustan Copper shares opened 2.5% higher and climbed over 7% percent to hit a fresh high.
Analysts advised investors to use the current rally to book profits ahead of the Budget.
While 2025 has been crucial for establishing the clinical credibility of GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro), 2026 will mark the 'patent cliff' that will democratise weight loss in India, transforming a luxury lifestyle treatment into a mass-market commodity.
Canara HSBC Life Insurance shares have risen about 25.4% since their listing in October.
The stock opened at Rs 166.50, up 2.39 percent from its previous close, and climbed to an intraday high of Rs 172.50, marking a gain of 7.23 percent.
Shares of the company opened gap-up with a gain of 2.95 percent and touched an intraday high of Rs 764.80, up 7.57 percent.
Expectations surrounding the upcoming Budget is also seen as a trigger amid possibility of capital expenditure plans and new project announcements.
The Nifty index showed losses for the third week, but momentum remains positive. Midcap and smallcap indices closed higher, signaling potential market recovery
The move is part of its broader strategy to build an integrated ecosystem around its electric two-wheelers.
The agreement gives Cipla sole rights to sell and distribute the two Corex variants along with some other drugs Pfizer will continue to manufacture and supply the products
ICICI Prudential AMC shares rose as much as 23 percent to Rs 2,663.40 on the NSE on the debut day.